Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Payables and Accruals [Abstract] | ||
| Employee-related expenses, including Restructuring Liability (Note 12) | $ 11,136 | $ 5,852 |
| Professional fees | 1,615 | 1,461 |
| Clinical expenses | 79 | 3,835 |
| Manufacturing expenses | 50 | 516 |
| Research and development expenses | 83 | 872 |
| Accrued up-front license payment (Note 10) | 45,000 | 0 |
| Other | 141 | 356 |
| Total accrued liabilities | $ 58,104 | $ 12,892 |
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Accrued research and development expenses current. No definition available.
|
| X | ||||||||||
- Definition Accrued up-front license payment. No definition available.
|
| X | ||||||||||
- Definition Clinical expenses, current. No definition available.
|
| X | ||||||||||
- Definition Manufacturing expenses, current. No definition available.
|